Nucleic acid electrophoresis and blotting is technique is used to separate nucleic acid molecules and identify specific fragments based. In electrophoresis, charged particles of nucleic acid are separated into DNA, RNA and proteins by its size or charge.
In nucleic acid electrophoresis and blotting method charged molecules are transported through solvent by an applied electric field for molecules to migrate towards the oppositely charged electrode. Nucleic acid electrophoresis and blotting procedure has clinical application in detecting the presence of specific protein in a complex mixture of protein in the body.
It is also used in diagnostic tests for diseases like AIDS and few neurodegenerative disorders. According to the AIDS Virus Education Research Trust (AVERT), approximately 37.9 people suffered from HIV globally in 2018.
Reduced and delayed physician visits and hospitalization is expected to reduce the demand for nucleic acid electrophoresis and blotting market for short-term. However, this is expected to balance in long term scenario and growth trends will remain positive for the next decade.
Research and development activities of nucleic acid electrophoresis and blotting market are expected to hamper due to nation-wide lockdown situation across the majority of countries in the world amid Covid-19 pandemic.
The rise in the prevalence of HIV infections is expected to drive nucleic acid electrophoresis and blotting market growth. With an increase in research and development activities for the genomics and proteomics, the leading industry players are investing in the nucleic acid electrophoresis and blotting market.
Increasing application of western blotting is expected to drive nucleic acid electrophoresis and blotting market growth. Government initiatives to create awareness about HIV tend to increase its diagnostic rate and fuel nucleic acid electrophoresis and blotting market growth.
For instance, in India, the National AIDS Control Programme (NACP) focuses on information, education and communication to control the spread of HIV. The requirement of highly skilled labour can hinder nucleic acid electrophoresis and blotting market growth. Alternative technologies offering more efficient results are expected to challenge nucleic acid electrophoresis and blotting market growth during the forecast period.
Gel electrophoresis is expected to generate the majority revenue share of nucleic acid electrophoresis and blotting market. Based on application, the diagnostic segment will dominate nucleic acid electrophoresis and blotting market during the forecast period with the increasing prevalence of HIV infections.
Whereas, research and development will observe a significant rise in nucleic acid electrophoresis and blotting market with increasing investments. Hospitals and biopharmaceutical companies are leading end-users of nucleic acid electrophoresis and blotting market due to increased diagnostics and research and development activities.
The high rate of prevalence of HIV infections increases the demand for nucleic acid electrophoresis and blotting market in North America. Europe is the second leading region in nucleic acid electrophoresis and blotting market with increased investments towards research and development activities.
Asia-pacific is lucrative with a higher growth rate in the nucleic acid electrophoresis and blotting market during the forecast period with a large patient population in the region. The Middle East and Africa are expected to observe the least growth in nucleic acid electrophoresis and blotting market due to less healthcare expenditure in the region.
The global nucleic acid electrophoresis and blotting market is segmented based on the type of electrophoresis type, application, end-user and region.
Explore Similar Insights
Nucleic acid electrophoresis and blotting market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
